Understanding and Navigating the Laws and Regulations Governing Pain Relief With Opioids

Recent reports suggest that many healthcare practitioners express concern about prescribing controlled substances, including opioid analgesics, to patients with chronic pain, especially chronic noncancer pain.[1-4] Two of the primary causes of such concern are the reluctance to contribute to drug abuse, addiction, and diversion,[5-7] and the possibility of being investigated or disciplined by a regulatory agency.[6,8-10] Given the general dearth of specialists to whom patients with chronic pain can be referred, especially if the patient has a history of substance abuse or current addictive disease, many patients with pain remain untreated or undertreated. As a result, efforts to reduce the public health problem of prescription drug abuse can be viewed as exacerbating the public health problem of uncontrolled pain. Likewise, many believe that the call to treat pain has contributed to the recent increase in the nonmedical use of prescription drugs.

[1]  A. Lipman A Review of “A Clinical Guide to Opioid Analgesia” , 2009 .

[2]  B. Mccarberg Responsible Opioid Prescribing: A Physician's Guide , 2008 .

[3]  A. Gilson,et al.  Improving State Pain Policies: Recent Progress and Continuing Opportunities , 2007, CA: a cancer journal for clinicians.

[4]  A. Gilson,et al.  State medical board members' beliefs about pain, addiction, and diversion and abuse: a changing regulatory environment. , 2007, The journal of pain : official journal of the American Pain Society.

[5]  Marlon P Mundt,et al.  Substance use disorders in a primary care sample receiving daily opioid therapy. , 2007, The journal of pain : official journal of the American Pain Society.

[6]  J. Benneyan,et al.  Foundations of Opioid Risk Management , 2007, The Clinical journal of pain.

[7]  J. L. Dahl,et al.  (996): Wisconsin physicians’ beliefs and attitudes about the use of opioid analgesics , 2006 .

[8]  A. Gilson,et al.  State policy affecting pain management: recent improvements and the positive impact of regulatory health policies. , 2005, Health policy.

[9]  M. Reidenberg,et al.  The risk of disciplinary action by state medical boards against physicians prescribing opioids. , 2005, Journal of pain and symptom management.

[10]  K. Foley Opioids and chronic neuropathic pain. , 2003, The New England journal of medicine.

[11]  A. Gilson,et al.  Pharmacists' knowledge of and attitudes toward opioid pain medications in relation to federal and state policies. , 2001, Journal of the American Pharmaceutical Association.

[12]  J. Giordano Interpreting Changes in State Laws and Regulations Governing the Use of Controlled Substances to Treat Pain , 2007 .